Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve
US9636364B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2014 |
| Grant date | May 2, 2017 |
| Priority date | — |
| Expiry date | Dec 1, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to methods for treating ocular contusion and blunt injury to the eye and for treating traumatic injury of the optic nerve. The invention is further directed to treating ocular contusion and blunt injury to the eye and for treating traumatic injury of the optic nerve by administering to a subject suffering from such conditions Amnion-derived Cellular Cytokine Solution (ACCS), including immediate-release, targeted-release, and sustained-release (SR) ACCS compositions (referred to herein as “SR-ACCS” compositions) and/or Amnion-derived Multipotent Progenitor (AMP) cell compositions. Such administration includes intranasal administration of ACCS and/or AMP cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.